Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles

Gene Therapy

Volumn 12, Issue 17, 2005, Pages 1305-1312

  Korpanty, G ^a   Chen, S ^a,b   Shohet, R V ^a   Ding, J ^b   Yang, B ^b   Frenkel, P A ^a,c   Grayburn, P A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Angiogenesis; Microbubbles; Myocardium; Ultrasound; VEGF

Indexed keywords

CELL MARKER; COMPLEMENTARY DNA; MESSENGER RNA; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC CODE; HEART MUSCLE REVASCULARIZATION; IN VIVO STUDY; MALE; MICROBUBBLE; MUSCLE LEVEL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; ULTRASOUND THERAPY;

ANIMALS; ARTERIOLES; CAPILLARIES; CORONARY VESSELS; DNA, COMPLEMENTARY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; INFUSIONS, INTRAVENOUS; MALE; MICROBUBBLES; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 28344432329     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302532     Document Type: Article

References (43)

1. Hammond HK, McKirnan MD. Angiogenic gene therapy for heart disease: A review of animal studies and clinical trials. Cardiovasc Res 2001; 49: 561-567.
2. Simons M et al. Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation 2000; 102: E73-E86.
3. Pecher P, Schumacher BA. Angiogenesis in ischemic human myocardium: clinical results after 3 years. Ann Thorac Surg 2000; 69: 1414-1419.
4. Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2003; 2: 863-871.
5. Rosengart TK et al. Six-month assessment of a Phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999; 230: 466-472.
6. Udelson JE et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 2000; 102: 1605-1610.
7. Henry TD et al. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003; 107: 1359-1365.
8. Simons M et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation 2002; 105: 788-793.
9. Laham RJ et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999; 100: 1865-1871.
10. Ruel M et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 2002; 124: 28-34.
11. Lederman RJ et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): A randomised trial. Lancet 2002; 359: 2053-2058.
12. Grines CL et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291-1297.
13. Losordo DW et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012-2018.
14. Hedman M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-2683.
15. Shohet RV et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101: 2554-2556.
16. Chen SY et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301-308.
17. Bekeredjian R et al. Ultrasound targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022-1026.
18. Dor Y et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002; 21: 1939-1947.
19. D'Amore PA. Capillary growth: A two-cell system. Semin Cancer Biol 1992; 3: 49-56.
20. Carmeliet P, Collen D. Genetic analysis of blood vessel formation. Role of endothelial versus smooth muscle cells. Trends Cardiovasc Med 1997; 7: 271-281.
21. Grosskreutz CL et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 1999; 58: 128-136.
22. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
23. Song J, Ming QI, Kaul S, Price RJ. Stimulation of arteriogenesis in skeletal muscle by Microbubbles destruction with ultrasound. Circulation 2002; 106: 1550-1555.
24. Greenleaf WJ et al. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998; 24: 587-595.
25. Miller DL, Gies RA. The interaction of ultrasonic heating and cavitation in vascular bioeffects on mouse intestine. Ultrasound Med Biol 1998; 24: 123-128.
26. Wu J, Ross JP, Chiu JF. Reparable sonoporation generated by microstreaming. J Acoust Soc Am 2002; 111: 1460-1464.
27. Kondo T, Misik V, Riesz P. Effect of gas-containing microspheres and echo contrast agents on free radical formation by ultrasound. Free Radic Biol Med 1998; 25: 605-612.
28. Skyba DM et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998; 98: 290-293.
29. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998; 98: 1264-1267.
30. Croll SD et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004; 187: 388-402.
31. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004; 172: 4618-4623.
32. Chavakis T et al. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): A link between inflammation and angiogenesis. FASEB J 2004; epub ahead of print.
33. Chen SY et al. Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography 2002; 19: 495-500.
34. Bekeredjian R et al. Effects of ultrasound targeted microbubble destruction on cardiac gene expression. J Ultrasound Med Biol 2004; 30: 539-543.
35. Hershey JC et al. Revascularization in the rabbit hindlimb: Dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 2001; 49: 618-625.
36. Helisch A, Schaper W. Arteriogenesis: The development and growth of collateral arteries. Microcirculation 2003; 10: 83-97.
37. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997; 3: 158-164.
38. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I. Angiogenic cytokines. Circulation 2004; 109: 2487-2491.
39. Moulton KS et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-4741.
40. Belgore F et al. Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries. J Clin Pathol 2004; 57: 266-272.
41. Khurana R et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 2004; 110: 2436-2443.
42. Templeton NS et al. Improved DNA: Liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997; 15: 647-652.
43. Maniatis T, Fritsch EF, Sambrook J. Extraction and Purification of plasmid DNA. In: Sambrook J (ed). Molecular Cloning Manual. Cold Spring Harbor Press: Cold Spring Harbor, NY, 1989, pp 1.38-1.39.